Comparison of enoxacin and norfloxacin in patients with cystitis. 1987

M Yamamoto, and T Nagai, and H Takaba, and J Hashimoto, and K Miyake
Department of Urology, Nagoya University School of Medicine.

The urinary antibacterial drugs enoxacin and norfloxacin were compared for efficacy and side effects in the treatment of lower urinary tract infections. Thirty-five patients received enoxacin and 25 received norfloxacin for one week. The antibacterial spectrum of enoxacin was noted to be better than that of norfloxacin, but both drugs performed well in clearing the infections caused by susceptible organisms. The incidence of side effects was higher with norfloxacin than with enoxacin.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009287 Naphthyridines A group of two-ring heterocyclic compounds consisting of a NAPHTHALENES double ring in which two carbon atoms, one per each ring, are replaced with nitrogens.
D009643 Norfloxacin A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE. AM-0715,AM-715,MK-0366,MK-366,MK0366,MK366,Noroxin,AM 0715,AM 715,AM0715,MK 0366,MK 366
D003556 Cystitis Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain. Cystitides
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Yamamoto, and T Nagai, and H Takaba, and J Hashimoto, and K Miyake
January 1985, The Journal of antimicrobial chemotherapy,
M Yamamoto, and T Nagai, and H Takaba, and J Hashimoto, and K Miyake
August 1988, Hinyokika kiyo. Acta urologica Japonica,
M Yamamoto, and T Nagai, and H Takaba, and J Hashimoto, and K Miyake
February 1985, European journal of clinical microbiology,
M Yamamoto, and T Nagai, and H Takaba, and J Hashimoto, and K Miyake
January 1990, Minerva urologica e nefrologica = The Italian journal of urology and nephrology,
M Yamamoto, and T Nagai, and H Takaba, and J Hashimoto, and K Miyake
September 1984, The Journal of antimicrobial chemotherapy,
M Yamamoto, and T Nagai, and H Takaba, and J Hashimoto, and K Miyake
September 1984, The Journal of antimicrobial chemotherapy,
M Yamamoto, and T Nagai, and H Takaba, and J Hashimoto, and K Miyake
April 1987, Diagnostic microbiology and infectious disease,
M Yamamoto, and T Nagai, and H Takaba, and J Hashimoto, and K Miyake
January 1988, European journal of clinical pharmacology,
M Yamamoto, and T Nagai, and H Takaba, and J Hashimoto, and K Miyake
January 1991, Journal of chemotherapy (Florence, Italy),
M Yamamoto, and T Nagai, and H Takaba, and J Hashimoto, and K Miyake
November 1987, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!